Literature DB >> 21193423

ETV6-ABL1-positive "chronic myeloid leukemia": clinical and molecular response to tyrosine kinase inhibition.

Fabiana Perna, Omar Abdel-Wahab, Ross L Levine, Suresh C Jhanwar, Kazunori Imada, Stephen D Nimer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21193423      PMCID： PMC3031707          DOI： 10.3324/haematol.2010.036673

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Molecular and cytogenetic characterization of a novel rearrangement involving chromosomes 9, 12, and 17 resulting in ETV6 (TEL) and ABL fusion.

Authors:  C A Tirado; S Sebastian; J O Moore; J Z Gong; B K Goodman
Journal:  Cancer Genet Cytogenet       Date:  2005-02

2.  Chronic phase of ETV6-ABL1 positive CML responds to imatinib.

Authors:  Norihiko Kawamata; Azadeh Dashti; Daning Lu; Becky Miller; H Phillip Koeffler; Rhona Schreck; Stephen Moore; Seishi Ogawa
Journal:  Genes Chromosomes Cancer       Date:  2008-10       Impact factor: 5.006

3.  Detection of dual TEL-ABL transcripts and a Tel-Abl protein containing phosphotyrosine in a chronic myeloid leukemia patient.

Authors:  H Lin; J Q Guo; M Andreeff; R B Arlinghaus
Journal:  Leukemia       Date:  2002-02       Impact factor: 11.528

4.  Acute leukemias with ETV6/ABL1 (TEL/ABL) fusion: poor prognosis and prenatal origin.

Authors:  Jan Zuna; Marketa Zaliova; Katerina Muzikova; Claus Meyer; Libuse Lizcova; Zuzana Zemanova; Jana Brezinova; Felix Votava; Rolf Marschalek; Jan Stary; Jan Trka
Journal:  Genes Chromosomes Cancer       Date:  2010-10       Impact factor: 5.006

5.  Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia.

Authors:  H Van Limbergen; H B Beverloo; E van Drunen; A Janssens; K Hählen; B Poppe; N Van Roy; P Marynen; A De Paepe; R Slater; F Speleman
Journal:  Genes Chromosomes Cancer       Date:  2001-03       Impact factor: 5.006

6.  BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion.

Authors:  P Andreasson; B Johansson; M Carlsson; I Jarlsfelt; T Fioretos; F Mitelman; M Höglund
Journal:  Genes Chromosomes Cancer       Date:  1997-11       Impact factor: 5.006

7.  Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors.

Authors:  Ranveer Nand; Christine Bryke; Steven H Kroft; Ajit Divgi; Christopher Bredeson; Ehab Atallah
Journal:  Leuk Res       Date:  2009-04-25       Impact factor: 3.156

8.  Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate.

Authors:  Aikaterini Barbouti; Tomas Ahlgren; Bertil Johansson; Mattias Höglund; Carin Lassen; Ingemar Turesson; Felix Mitelman; Thoas Fioretos
Journal:  Br J Haematol       Date:  2003-07       Impact factor: 6.998

9.  The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event.

Authors:  J W Janssen; S A Ridge; P Papadopoulos; F Cotter; W D Ludwig; C Fonatsch; H Rieder; W Ostertag; C R Bartram; L M Wiedemann
Journal:  Br J Haematol       Date:  1995-05       Impact factor: 6.998

Review 10.  Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature.

Authors:  Yi Kong Keung; Michael Beaty; William Steward; Bethy Jackle; Mark Pettnati
Journal:  Cancer Genet Cytogenet       Date:  2002-10-15
View more
  10 in total

Review 1.  Updates on eosinophilic disorders.

Authors:  Alexandar Tzankov; Kaaren K Reichard; Robert P Hasserjian; Daniel A Arber; Attilio Orazi; Sa A Wang
Journal:  Virchows Arch       Date:  2022-09-07       Impact factor: 4.535

2.  Characterization of leukemias with ETV6-ABL1 fusion.

Authors:  Marketa Zaliova; Anthony V Moorman; Giovanni Cazzaniga; Martin Stanulla; Richard C Harvey; Kathryn G Roberts; Sue L Heatley; Mignon L Loh; Marina Konopleva; I-Ming Chen; Olga Zimmermannova; Claire Schwab; Owen Smith; Marie-Joelle Mozziconacci; Christian Chabannon; Myungshin Kim; J H Frederik Falkenburg; Alice Norton; Karen Marshall; Oskar A Haas; Julia Starkova; Jan Stuchly; Stephen P Hunger; Deborah White; Charles G Mullighan; Cheryl L Willman; Jan Stary; Jan Trka; Jan Zuna
Journal:  Haematologica       Date:  2016-05-26       Impact factor: 9.941

3.  Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review.

Authors:  Katya Gancheva; Andres Virchis; Julie Howard-Reeves; Nick Cp Cross; Diana Brazma; Colin Grace; Paul Kotzampaltiris; Fedra Partheniou; Elisabeth Nacheva
Journal:  Mol Cytogenet       Date:  2013-09-20       Impact factor: 2.009

4.  An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL.

Authors:  Purvi M Kakadia; Ralf Schmidmaier; Andreas Völkl; Irene Schneider; Natalia Huk; Stephanie Schneider; Gerda Panzner; Ulrike Neidel; Barbara Fritz; Karsten Spiekermann; Stefan K Bohlander
Journal:  Leuk Res Rep       Date:  2016-10-14

5.  A Case of Chronic Myeloid Leukemia With Rare Variant ETV6/ABL1 Rearrangement.

Authors:  Soo In Choi; Mi Ae Jang; Woo Joon Jeong; Byung Ryul Jeon; Yong Wha Lee; Hee Bong Shin; Dae Sik Hong; You Kyoung Lee
Journal:  Ann Lab Med       Date:  2017-01       Impact factor: 3.464

6.  An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.

Authors:  O Zimmermannova; E Doktorova; J Stuchly; V Kanderova; D Kuzilkova; H Strnad; J Starkova; M Alberich-Jorda; J H F Falkenburg; J Trka; J Petrak; J Zuna; M Zaliova
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

7.  Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia.

Authors:  Jin-long Shi; Lin Fu; Qing Ang; Guo-jing Wang; Jun Zhu; Wei-dong Wang
Journal:  Oncotarget       Date:  2016-01-19

8.  A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature.

Authors:  Carlos A Tirado; Ken Siangchin; David S Shabsovich; Maryam Sharifian; Gary Schiller
Journal:  Biomark Res       Date:  2016-08-25

9.  [Acute myeloid leukemia with co-expression of TEL-ABL1 and NUP98-HOXA9 fusion genes: a case report and literature review].

Authors:  C Y Wu; Y L Li; X Y Dong; L Zhang; B J Shang; W Li; Z B Li; L Zhang; Z M Zhu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-07-14

10.  Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition.

Authors:  JinJuan Yao; Lianrong Xu; Umut Aypar; Howard J Meyerson; Dory Londono; Qi Gao; Jeeyeon Baik; James Dietz; Ryma Benayed; Allison Sigler; Mariko Yabe; Ahmet Dogan; Maria E Arcila; Mikhail Roshal; Yanming Zhang; Michael J Mauro; Wenbin Xiao
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.